OR8Q1P

Across TCGA pan-cancer cohorts, OR8Q1P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR8Q1P’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where OR8Q1P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR8Q1P is over-expressed in tumor.

PRAD, LUSC, and LIHC are the cancer types where OR8Q1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR8Q1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.052	.027	2	view →
LUSC	Male	All	+0.091	.046	1	view →
LIHC	All	All	+0.025	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

OR8Q1P–PRAD

Open the PRAD breakdown →